2161.HK HKSE
JBM (Healthcare) Limited
1W: -1.8%
1M: -11.0%
3M: -17.4%
YTD: -40.4%
1Y: -42.1%
3Y: +57.3%
5Y: +39.7%
HK$1.60 ($0.20)
-0.01 (-0.93%)
Weekly Expected Move ±2.6%
HK$2
HK$2
HK$2
HK$2
HK$2
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$227M
+18.7% ▲
5Y CAGR: +42.7%
Capital Expenditures
$21M
-105.7% ▼
5Y CAGR: +36.0%
Free Cash Flow
$206M
+13.8% ▲
5Y CAGR: +43.6%
Dividends Paid
$79M
-49.3% ▼
Buybacks
$12M
+86.7% ▲
Net Change in Cash
$65M
+667.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $23M | $25M | $57M | $130M | $242M |
| Depreciation & Amort. | $44M | $48M | $44M | $47M | $52M |
| Stock-Based Comp. | $0 | $0 | $253K | $9M | $6M |
| Change in Working Capital | -$24M | -$12M | $35M | -$13M | -$31M |
| Other Non-Cash Items | $16M | -$109K | $62M | $18M | -$42M |
| Operating Cash Flow | $59M | $60M | $146M | $191M | $227M |
| — Investing Activities — | |||||
| Capital Expenditures | -$23M | -$7M | -$8M | -$10M | -$21M |
| Acquisitions (Net) | -$2M | -$511K | $2M | $163K | -$101M |
| Investment Purchases | -$2M | -$511K | -$823K | $0 | -$369K |
| Investment Sales | $3M | $1M | -$1M | $0 | $283K |
| Other Investing | -$1M | -$493K | $1M | $18M | $2M |
| Investing Cash Flow | -$25M | -$8M | -$7M | $8M | -$120M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$162M | -$65M | -$27M | -$48M | $35M |
| Stock Repurchased | $0 | $0 | $0 | -$89M | -$12M |
| Dividends Paid | $0 | $0 | -$4M | -$53M | -$79M |
| Other Financing | -$2M | -$11M | -$19M | -$15M | $25M |
| Financing Cash Flow | -$14M | -$77M | -$56M | -$211M | -$42M |
| Net Change in Cash | $22M | -$25M | $82M | -$11M | $65M |
| Cash End of Period | $94M | $70M | $152M | $141M | $206M |
| Free Cash Flow | $36M | $53M | $138M | $181M | $206M |